Synthesis and biological evaluation of peptide-derived TSLP inhibitors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Seonghu | - |
dc.contributor.author | Park, Yeeun | - |
dc.contributor.author | Son, Sang-Hyun | - |
dc.contributor.author | Lee, Kiho | - |
dc.contributor.author | Jung, Yong Woo | - |
dc.contributor.author | Lee, Ki Yong | - |
dc.contributor.author | Jeon, Young Ho | - |
dc.contributor.author | Byun, Youngjoo | - |
dc.date.accessioned | 2021-09-03T00:08:53Z | - |
dc.date.available | 2021-09-03T00:08:53Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2017-10-15 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/81898 | - |
dc.description.abstract | Thymic stromal lymphopoietin (TSLP) is a type II cytokine which is associated with most inflammatory allergic disorders in humans. It is produced mainly by epithelial cells with important role in the development of chronic inflammatory diseases by activating T-helper cell type-2 (T(H)2) pathways. In this study, a total of 16 peptides were prepared by solid phase peptide synthesis based on amino acid sequences of the interface between TSLP and TSLP receptor. Their TSLP inhibition activities were determined by ELISA assay. Among them, three peptides (6-8) exhibited >50% inhibition at concentration of 0.3 mM. They can be used as hit compounds for developing peptide-based TSLP inhibitors. (C) 2017 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | THYMIC STROMAL LYMPHOPOIETIN | - |
dc.subject | RECEPTOR | - |
dc.subject | CLONING | - |
dc.subject | COMPLEX | - |
dc.subject | ALLERGY | - |
dc.subject | INFLAMMATION | - |
dc.subject | MECHANISMS | - |
dc.subject | ASTHMA | - |
dc.subject | STAT5 | - |
dc.title | Synthesis and biological evaluation of peptide-derived TSLP inhibitors | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Son, Sang-Hyun | - |
dc.contributor.affiliatedAuthor | Jung, Yong Woo | - |
dc.contributor.affiliatedAuthor | Lee, Ki Yong | - |
dc.contributor.affiliatedAuthor | Jeon, Young Ho | - |
dc.contributor.affiliatedAuthor | Byun, Youngjoo | - |
dc.identifier.doi | 10.1016/j.bmcl.2017.09.010 | - |
dc.identifier.scopusid | 2-s2.0-85029547109 | - |
dc.identifier.wosid | 000412863700022 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.27, no.20, pp.4710 - 4713 | - |
dc.relation.isPartOf | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 27 | - |
dc.citation.number | 20 | - |
dc.citation.startPage | 4710 | - |
dc.citation.endPage | 4713 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.subject.keywordPlus | THYMIC STROMAL LYMPHOPOIETIN | - |
dc.subject.keywordPlus | RECEPTOR | - |
dc.subject.keywordPlus | CLONING | - |
dc.subject.keywordPlus | COMPLEX | - |
dc.subject.keywordPlus | ALLERGY | - |
dc.subject.keywordPlus | INFLAMMATION | - |
dc.subject.keywordPlus | MECHANISMS | - |
dc.subject.keywordPlus | ASTHMA | - |
dc.subject.keywordPlus | STAT5 | - |
dc.subject.keywordAuthor | Allergic disease | - |
dc.subject.keywordAuthor | TSLP inhibitors | - |
dc.subject.keywordAuthor | Peptides | - |
dc.subject.keywordAuthor | TSLP receptors | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.